Last updated on December 2018

Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia


Brief description of study

The purpose of the study is to determine the maximum tolerated dose and assess the safety, tolerability and activity of carfilzomib, alone and in combination with induction chemotherapy, in children with relapsed or refractory acute lymphoblastic leukemia (ALL).

Clinical Study Identifier: NCT02303821

Find a site near you

Start Over

Children's Hospital Los Angeles

Los Angeles, CA United States
  Connect »

All Childrens Hospital

Saint Petersburg, FL United States
  Connect »

Johns Hopkins University

Baltimore, MD United States
  Connect »

Primary Children's Hospital

Salt Lake City, UT United States
  Connect »

Medical College of Wisconsin

Milwaukee, WI United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.